UK blood cancer patients get early access to BMS drug
Nivolumab made available ahead of EU approval in relapsed cHL.
X
UK blood cancer patients get early access to BMS drug
https://pharmaphorum.com/news/uk-blood-cancer-patients-get-early-access-bms-drug/
